PubMed

Tocilizumab for rheumatoid arthritis.

[No authors listed]

Drug Ther Bull. 2010 Jan;48(1):9-12. Review.PMID: 20040568 [PubMed - indexed for MEDLINE]Related citations

Newer biological agents in the treatment of rheumatoid arthritis: do the benefits outweigh the risks?

Nurmohamed MT.

Drugs. 2009 Oct 22;69(15):2035-43. doi: 10.2165/11318290-000000000-00000.PMID: 19791825 [PubMed - indexed for MEDLINE]Related citations

[New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor)]

Nasonov EL.

Ter Arkh. 2010;82(5):64-71. Review. Russian. PMID: 20597275 [PubMed - indexed for MEDLINE]Related citations

[Guidelines for usage of biological agents for treatment of rheumatoid arthritis]

Takeuchi T.

Nippon Rinsho. 2005 Jan;63 Suppl 1:444-7. Review. Japanese. No abstract available. PMID: 15799396 [PubMed - indexed for MEDLINE]Related citations

Rituximab (Rituxan) for rheumatoid arthritis.

[No authors listed]

Med Lett Drugs Ther. 2006 Apr 24;48(1233):34-5. Review. No abstract available. PMID: 16625143 [PubMed - indexed for MEDLINE]Related citations

FDA approves tocilizumab to treat rheumatoid arthritis.

Thompson CA.

Am J Health Syst Pharm. 2010 Feb 15;67(4):254. No abstract available. PMID: 20133526 [PubMed - indexed for MEDLINE]Related citations

Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis.

Koike R, Harigai M, Atsumi T, Amano K, Kawai S, Saito K, Saito T, Yamamura M, Matsubara T, Miyasaka N.

Mod Rheumatol. 2009;19(4):351-7. Epub 2009 Jul 10.PMID: 19590933 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials.

Kavanaugh A.

Bull NYU Hosp Jt Dis. 2007;65 Suppl 1:S16-20. Review.PMID: 17708740 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Infliximab: a pharmacoeconomic review of its use in rheumatoid arthritis.

Lyseng-Williamson KA, Foster RH.

Pharmacoeconomics. 2004;22(2):107-32. Review.PMID: 14731052 [PubMed - indexed for MEDLINE]Related citations

Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.

[No authors listed]

Prescrire Int. 2009 Oct;18(103):198-201.PMID: 19882783 [PubMed - indexed for MEDLINE]Related citations

Infliximab: a new treatment for rheumatoid arthritis.

Emery P.

Hosp Med. 2001 Mar;62(3):150-2. Review.PMID: 11291464 [PubMed - indexed for MEDLINE]Related citations

Tocilizumab: a review of its use in the management of rheumatoid arthritis.

Oldfield V, Dhillon S, Plosker GL.

Drugs. 2009;69(5):609-32. doi: 10.2165/00003495-200969050-00007. Review.PMID: 19368420 [PubMed - indexed for MEDLINE]Related citations

Cost-effectiveness of anti-tumor necrosis factor agents.

Wong JB.

Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S65-70. Review.PMID: 15552517 [PubMed - indexed for MEDLINE]Related citations

Interleukin-6 in rheumatoid arthritis.

Nishimoto N.

Curr Opin Rheumatol. 2006 May;18(3):277-81. Review.PMID: 16582692 [PubMed - indexed for MEDLINE]Related citations

New therapies for treatment of rheumatoid arthritis.

Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P.

Lancet. 2007 Dec 1;370(9602):1861-74. Review.PMID: 17570481 [PubMed - indexed for MEDLINE]Related citations

Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.

Soriano ER, Galarza-Maldonado C, Cardiel MH, Pons-Estel BA, Massardo L, Caballero-Uribe CV, Achurra-Castillo AF, Barile-Fabris LA, Chávez-Corrales J, Díaz-Coto JF, Esteva-Spinetti MH, Guibert-Toledano M, Palazuelos FI, Keiserman MW, Lomonte AV, Mota LM, Pineda Villaseñor C, Alarcón GS; GLADAR (Grupo Latino Americano de Estudio de Artritis Reumatoide).

Rheumatology (Oxford). 2008 Jul;47(7):1097-9. Epub 2008 May 7. No abstract available. PMID: 18463144 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Inhibiting interleukin-6 in rheumatoid arthritis.

Choy E.

Curr Rheumatol Rep. 2008 Oct;10(5):413-7.PMID: 18817647 [PubMed - indexed for MEDLINE]Related citations

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study.

Jones G, Sebba A, Gu J, Lowenstein MB, Calvo A, Gomez-Reino JJ, Siri DA, Tomsic M, Alecock E, Woodworth T, Genovese MC.

Ann Rheum Dis. 2010 Jan;69(1):88-96. Epub .PMID: 19297346 [PubMed - indexed for MEDLINE]Related citations

Clinical image: hidden costs of anti-tumor necrosis factor alpha therapy.

Mulherin D, Sheeran TP.

Arthritis Rheum. 2003 Mar;48(3):868. No abstract available. PMID: 12632461 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

New antibody approved for treatment of rheumatoid arthritis.

Piascik P.

J Am Pharm Assoc (Wash). 2003 Mar-Apr;43(2):327-8. Review.PMID: 12688444 [PubMed - indexed for MEDLINE]Related citations